NeuroSense Therapeutics Ltd. (NRSN) reporting calendar
NeuroSense Therapeutics Ltd. files periodic reports with the SEC as NRSN on Nasdaq. Atlas tracks 5 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 31 Mar 2026
- Reports on record
- 5
Open NRSN market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001213900-26-036970 |
| 20-F | 31 Dec 2024 | 7 Apr 2025 | 97 days | 0001213900-25-029464 |
| 20-F | 31 Dec 2023 | 4 Apr 2024 | 95 days | 0001213900-24-030439 |
| 20-F | 31 Dec 2022 | 22 Mar 2023 | 81 days | 0001213900-23-021883 |
| 20-F | 31 Dec 2021 | 14 Apr 2022 | 104 days | 0001213900-22-019888 |
Source: SEC EDGAR company submissions for CIK 0001875091. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.